🇺🇸 FDA
Pipeline program

Linaclotide

MCP-103-309

Phase 3 small_molecule completed

Quick answer

Linaclotide for Chronic Idiopathic Constipation is a Phase 3 program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IRONWOOD PHARMACEUTICALS INC
Indication
Chronic Idiopathic Constipation
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials